We are hosting our first European conference on Drug Discovery for Neurodegeneration: An Educational Course on Translating Research into Drugs which is based on the ADDF’s annual US-based Drug Discovery for Neurodegeneration conference, which was established in 2007 to meet the following objectives:

1. Train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease (NDD)

2. Provide a platform to exchange ideas, knowledge and resources about drug discovery for NDD

3. Stimulate preclinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of NDD

4. Build public-private partnerships that will accelerate drug discovery for NDD

This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The program will also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to NDD.